Intraperitoneal therapy for ovarian cancer

David S Alberts, Lisa M. Hess, Mary C. Clouser

Research output: Book/ReportBook

Abstract

Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Therapy for Ovarian Cancer have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training, oncologists and basic and translational scientists in training.

Original languageEnglish (US)
PublisherSpringer Berlin Heidelberg
Number of pages153
ISBN (Print)9783642121296
DOIs
StatePublished - 2010

Fingerprint

Ovarian Neoplasms
Phase III Clinical Trials
Phase II Clinical Trials
Clinical Trials, Phase I
Therapeutics
Pharmaceutical Preparations
Fever
Catheters
Research Personnel
Clinical Trials
Guidelines
Drug Therapy
Oncologists

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Alberts, D. S., Hess, L. M., & Clouser, M. C. (2010). Intraperitoneal therapy for ovarian cancer. Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-12130-2

Intraperitoneal therapy for ovarian cancer. / Alberts, David S; Hess, Lisa M.; Clouser, Mary C.

Springer Berlin Heidelberg, 2010. 153 p.

Research output: Book/ReportBook

Alberts DS, Hess LM, Clouser MC. Intraperitoneal therapy for ovarian cancer. Springer Berlin Heidelberg, 2010. 153 p. https://doi.org/10.1007/978-3-642-12130-2
Alberts, David S ; Hess, Lisa M. ; Clouser, Mary C. / Intraperitoneal therapy for ovarian cancer. Springer Berlin Heidelberg, 2010. 153 p.
@book{f0972c66295d4b91a8cd88316950a924,
title = "Intraperitoneal therapy for ovarian cancer",
abstract = "Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Therapy for Ovarian Cancer have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training, oncologists and basic and translational scientists in training.",
author = "Alberts, {David S} and Hess, {Lisa M.} and Clouser, {Mary C.}",
year = "2010",
doi = "10.1007/978-3-642-12130-2",
language = "English (US)",
isbn = "9783642121296",
publisher = "Springer Berlin Heidelberg",

}

TY - BOOK

T1 - Intraperitoneal therapy for ovarian cancer

AU - Alberts, David S

AU - Hess, Lisa M.

AU - Clouser, Mary C.

PY - 2010

Y1 - 2010

N2 - Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Therapy for Ovarian Cancer have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training, oncologists and basic and translational scientists in training.

AB - Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Therapy for Ovarian Cancer have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training, oncologists and basic and translational scientists in training.

UR - http://www.scopus.com/inward/record.url?scp=84895306506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895306506&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-12130-2

DO - 10.1007/978-3-642-12130-2

M3 - Book

AN - SCOPUS:84895306506

SN - 9783642121296

BT - Intraperitoneal therapy for ovarian cancer

PB - Springer Berlin Heidelberg

ER -